protein
| HOXA7 and HOXA9, coactivating in acute myeloid leukemia |
|
PBX1, PBX2, PBX3 DNA-binding partner |
|
collaboration between IRF8 deficiency and MEIS1/MEIS3 in the acceleration of chronic myeloid leukemia-like disease |
|
co-operation between TLX1 and MEIS1, MEIS2 proteins may have a significant role in T-cell leukemogenesis |
|
binding of MEIS1 to the mitochondrial promoter region |
|
interaction with PKNOX1 (C-terminal domain of MEIS1 confers to PKNOX1 an ectopic transactivating function that promotes leukemogenesis by regulating expression of genes involved in chromatin accessibility and cell cycle progression) |
|
is a direct and prominent target of GFI1B (direct yet differential regulation of MEIS1 transcription by GFI1B in distinct hematopoietic lineages) |
|
MEIS1 regulates FOXN4 expression during retinal progenitor cell differentiation |
|
PKNOX1 posttranslationally controls the level of MEIS1, decreasing its stability by sequestering PBX1 |
|
HOXA2 operates as a tissue-specific cofactor, enhancing MEIS1 binding to specific sites that provide the IIBA with its anatomical identity |
|
crucial role for RING1-dependent repression of MEIS2 and likely also MEIS1 for distal specification |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| gain of function
|
coactivated by HOXA9 in myeloid leukemias, in infant acute lymphoblastic leukemia | tumoral
|  
|  
|  
| gain of function
|
in neuroblastoma cell lines and with HOXB3 in acute myeloid leukemia | tumoral
|  
| amplification
|  
|  
|
or overexpressed in neuroblastoma, erythroleukemia or medulloblastoma | tumoral
|  
|  
| --over
|  
|
represses myeloid-specific gene transcription, thereby contributing to differentiation block in leukemogenesis | tumoral
|  
|  
| --over
|  
|
extensively expressed in ovarian carcinomas and may play a role in ovarian carcinogenesis | constitutional
|  
|  
|  
| loss of function
|
results in cardiac anomalies that resemble those caused by PBX mutations | tumoral
|  
|  
| --over
|  
|
of HOXA9 and HOXA10 and their essential cofactor MEIS1 in cells with the t(4;11) chromosome translocation and MLL-AF4 in acute leukemia | |